← Evidence map

TrialLung cancer (Amsterdam, Netherlands)2026

Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials.

Yating Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41666849